Metabolomics and Biomarkers for Drug Discovery
AbstractMetabolomics and biomarkers are increasingly used in drug discovery and development, and are applied to personalized medicine. Progress in these research areas has increased our understanding of disease pathology and improved therapeutic strategies for many diseases with unmet challenges. Further advances will ultimately result in the development of better drugs and breakthrough therapies, which will benefit millions of patients suffering from chronic and life-threatening diseases worldwide. View Full-Text
Share & Cite This Article
Yeung, P.K. Metabolomics and Biomarkers for Drug Discovery. Metabolites 2018, 8, 11.
Yeung PK. Metabolomics and Biomarkers for Drug Discovery. Metabolites. 2018; 8(1):11.Chicago/Turabian Style
Yeung, Pollen K. 2018. "Metabolomics and Biomarkers for Drug Discovery." Metabolites 8, no. 1: 11.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.